Novel functional profiling approach combining reverse phase protein microarrays and human 3-D ex vivo tissue cultures: Expression of apoptosis-related proteins in human colon cancer

Proteomics

Volumn 9, Issue 13, 2009, Pages 3535-3548

  Pirnia, Farzaneh ^a   Pawlak, Michael ^b   Thallinger, Gerhard G ^c   Gierke, Berthold ^b   Templin, Markus F ^b   Kappeler, Andi ^d   Betticher, Daniel C ^a   Gloor, Beat ^a   Borner, Markus M ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b UNIVERSITY OF TÜBINGEN   (Germany)

^c GRAZ UNIVERSITY OF TECHNOLOGY   (Austria)

^d UNIVERSITY OF BERN   (Switzerland)

Author keywords

Apoptosis; Colon cancer; Protein automated identification

Indexed keywords

BIM PROTEIN; CARCINOEMBRYONIC ANTIGEN; CASPASE 3; CASPASE 7; CASPASE 8; CASPASE 9; CELL PROTEIN; KI 67 ANTIGEN; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROTEIN BAD; PROTEIN BAK; PROTEIN BAX; PROTEIN BIK; PROTEIN BMF; PROTEIN BOK; PROTEIN P21; PROTEIN P53; PROTEIN P73; PUMA PROTEIN; TRANSCRIPTION FACTOR TWIST; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CANCER RESEARCH; CLINICAL ARTICLE; COLON; COLORECTAL CANCER; CONTROLLED STUDY; EX VIVO STUDY; FEASIBILITY STUDY; FUNCTIONAL PROTEOMICS; HUMAN; HUMAN TISSUE; LIVER METASTASIS; PANCREAS CANCER; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; PROTEIN MICROARRAY; PROTEIN MODIFICATION; REVERSE PHASE PROTEIN MICROARRAY; THREE DIMENSIONAL IMAGING; TISSUE CULTURE;

APOPTOSIS REGULATORY PROTEINS; CARCINOEMBRYONIC ANTIGEN; CLUSTER ANALYSIS; COLONIC NEOPLASMS; HUMANS; PROTEIN ARRAY ANALYSIS; REPRODUCIBILITY OF RESULTS; SIGNAL TRANSDUCTION; TISSUE CULTURE TECHNIQUES;

EID: 67651202267     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.200800159     Document Type: Article

References (28)

1. Hanash, S., Disease proteomics. Nature 2003, 422, 226-232.
2. Zhu, H., Bilgin, M., Bangham, R., Hall, D. et al., Global analysis of protein activities using proteome chips. Science 2001, 293, 2101-2105.
3. Nishizuka, S., Chen, S. T., Gwadry, F. G., Alexander, J. et al., Diagnostic markers that distinguish colon and ovarian adenocarcinomas: identification by genomic, proteomic, and tissue array profiling. Cancer Res. 2003, 63, 5243-5250.
4. Stoll, D., Templin, M. F., Bachmann, J., Joos, T. O., Protein microarrays: applications and future challenges. Curr. Opin. Drug Discov. Devel. 2005, 8, 239-252.
5. Wulfkuhle, J. D., Edmiston, K. H., Liotta, L. A., Petricoin 3rd. E. F., Technology insight: pharmacoproteomics for cancer - promises of patient-tailored medicine using protein microarrays. Nat. Clin. Pract. Oncol. 2006, 3, 256-268.
6. Paweletz, C. P., Charboneau, L., Bichsel, V. E., Simone, N. L. et al., Reverse phase protein microarrays which capture disease progression show activation of pro-survival pathways at the cancer invasion front. Oncogene 2001, 20, 1981-1989.
7. Chan, S. M., Ermann, J., Su, L., Fathman, C. G. et al., Protein microarrays for multiplex analysis of signal transduction pathways. Nat. Med. 2004, 10, 1390-1396.
8. Nishizuka, S., Charboneau, L., Young, L., Major, S. et al., Proteomic profiling of the NCI-60 cancer cell lines using new high-density reverse-phase lysate microarrays. Proc. Natl. Acad. Sci. USA 2003, 100, 14229-14234.
9. Grubb, R. L., Calvert, V. S., Wulkuhle, J. D., Paweletz, C. P. et al., Signal pathway profiling of prostate cancer using reverse phase protein arrays. Proteomics 2003, 3, 2142-2146.
10. Sheehan, K. M., Calvert, V. S., Kay, E. W., Lu, Y. et al., Use of reverse phase protein microarrays and reference standard development for molecular network analysis of metastatic ovarian carcinoma. Mol. Cell. Proteomics 2005, 4, 346-355.
11. Pirnia, F., Frese, S., Gloor, B., Hotz, M. A. et al., Ex vivo assessment of chemotherapy-induced apoptosis and associated molecular changes in patient tumor samples. Anticancer Res. 2006, 26, 1765-1772.
12. Furukawa, T., Kubota, T., Watanabe, M., Takahara, T. et al., High in vitro-in vivo correlation of drug response using sponge-gel-supported three-dimensional histoculture and the MTT end point. Int. J. Cancer 1992, 51, 489-498.
13. Green, S. K., Frankel, A., Kerbel, R. S., Adhesion-dependent multicellular drug resistance. Anticancer Drug Des. 1999, 14, 153-168.
14. Kerbel, R. S., St Croix, B., Florenes, V. A., Rak, J., Induction and reversal of cell adhesion-dependent multicellular drug resistance in solid breast tumors. Hum. Cell 1996, 9, 257-264.
15. Nakamura, T., Kato, Y., Fuji, H., Horiuchi, T. et al., Ecadherin-dependent intercellular adhesion enhances chemoresistance. Int. J. Mol. Med. 2003, 12, 693-700.
16. Hoffman, R. M., In vitro sensitivity assays in cancer: a review, analysis, and prognosis. J. Clin. Lab Anal. 1991, 5, 133-143.
17. Kubota, T., Sasano, N., Abe, O., Nakao, I. et al., Potential of the histoculture drug-response assay to contribute to cancer patient survival. Clin. Cancer Res. 1995, 1, 1537-1543.
18. Singh, B., Li, R., Xu, L., Poluri, A. et al., Prediction of survival in patients with head and neck cancer using the histoculture drug response assay. Head Neck 2002, 24, 437-442.
19. Tanino, H., Oura, S., Hoffman, R. M., Kubota, T. et al., Acquisition of multidrug resistance in recurrent breast cancer demonstrated by the histoculture drug response assay. Anticancer Res. 2001, 21, 4083-4086.
20. Vescio, R. A., Redfern, C. H., Nelson, T. J., Ugoretz, S. et al., In vivo-like drug responses of human tumors growing in three-dimensional gel-supported primary culture. Proc. Natl. Acad. Sci. USA 1987, 84, 5029-5033.
21. Pawlak, M., Schick, E., Bopp, M. A., Schneider, M. J. et al., Zeptosens' protein microarrays: a novel high performance microarray platform for low abundance protein analysis. Proteomics 2002, 2, 383-393.
22. R Development Core Team, R: A Language and Environment for Statistical Computing, R Foundation for Statistical Computing, Vienna 2005.
23. Ge, Y., Dudoit, S., Speed, T. P., Resampling-based multiple testing for microarray data analysis. Test 2003, 12, 1-44.
24. Sturn, A., Quackenbush, J., Trajanoski, Z., Genesis: cluster analysis of microarray data. Bioinformatics 2002, 18, 207-208.
25. Aquino, A., Formica, V., Prete, S. P., Correale, P. P. et al., Drug-induced increase of carcinoembryonic antigen expression in cancer cells. Pharmacol. Res. 2004, 49, 383-396.
26. Pirnia, F., Schneider, E., Betticher, D. C., Borner, M. M., Mitomycin C induces apoptosis and Caspase -8 and -9 processing through a Caspase -3 and Fas-independent pathway. Cell Death Differ. 2002, 9, 905-914.
27. Borner, M. M., Myers, C. E., Sartor, O., Sei, Y. et al., Drug-induced apoptosis is not necessarily dependent on macromolecular synthesis or proliferation in the p53-negative human prostate cancer cell line PC-3. Cancer Res. 1995, 55, 2122-2128.
28. Dixon, S. C., Soriano, B. J., Lush, R. M., Borner, M. M. et al., Apoptosis: its role in the development of malignancies and its potential as a novel therapeutic target. Ann. Pharmacother. 1997, 31, 76-82.